Six young scientific and technological personnel in Fengxian entered the Shanghai selection star program!Focus on biomedicine and other fields!

A few days ago, the results of Shanghai's 2022 Qiming Star Program were released. Six young scientific and technological personnel in Fengxian District were selected, and the number of projects hit a record high.

Six youth scientific and technological personnel are: Shanghai Chengjili Special Asphalt Co., Ltd. Chai Chongchong, Shanghai Junshi Biological Engineering Co., Ltd. Liu Hongchuan, Mengyang Pharmaceutical (Shanghai) Co., Ltd. Huang Qian, Shanghai Runzhuang Agricultural Technology Co., Ltd. Liu Hongjian Zhao Zhiyong, Shanghai Guosen Biotechnology Co., Ltd., Zhao Yingbo, Shanghai Zhenge Biotechnology Co., Ltd..

As the backbone researcher of Shanghai Junshi Biological Engineering Co., Ltd., Liu Hongchuan has deeply cultivated tumor immunity in the past 10 years and is committed to developing innovative drugs. This time his subject focused on the design of antibody-cytokine drugs with conditional activation. "We hope that through the unique antibody-cytokine drug structure design, it will bring safer and better medication effects." Liu Hongchuan introduced, "This is also the world's first unique cover design based on biased IL-2B antibodies-cells-cells Factors can realize the conditional activation of the micro -environment of the tumor, bring higher treatment safety windows, solve the unsatisfactory clinical needs, and bring the gospel for people's health. "

Linoleum

Lammid is a rare and medicinal fungus. It not only has high nutritional value, but also has high economic value. It supports the "rich umbrella" for poor households in many regions. As the technical manager of Shanghai Guosen Biotechnology Co., Ltd., Zhao Zhiyong has been engaged in food safety assessment and prevention and control technology for a long time. After 3 years of work, his team focuses on this subject. Research on key technologies of biological toxicity and its reduction of control. "On the one hand, we want to prove whether cadmium combination protein will endanger human health." Zhao Zhiyong said, "On the other hand, hopes to build an effective reduction control technology to reduce cadmium pollution of more Industrial development contributes to farmers' income. "Speaking of being selected for the Qixing project, Zhao Zhiyong, 34 years old, said that the project can be said to be a key step in the growth of young science and technology. Given a lot of confidence for young people to engage in scientific research.

Mengyang Pharmaceutical (Shanghai) Co., Ltd. focuses on the "treatment drug professional manufacturer of tumor treatment toxic and side effects", and is committed to becoming a leading drug research and development and manufacturing enterprise that focuses on solving tumor treatment toxicity and side effects. As the company's young scientific researchers, Huang Qian is committed to developing a safe and effective drug (CIPN -related) neuropathological pain drugs caused by a safe and effective prevention and treatment of chemotherapy. "We hope to evaluate the role and influence of Chinese medicine activity monomers in the form of modeling models, greatly shorten the development process of new drugs, and develop a oral, safe, and effective use of neuropathological pain caused by chemotherapy in a short time. The new medicine is to solve the clinical needs far and not met. "Huang Qian introduced.

- END -